These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8615009)

  • 41. Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis.
    Takada S; Tsuchida N; Kobayashi M; Koike K
    J Cancer Res Clin Oncol; 1995; 121(9-10):593-601. PubMed ID: 7559743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression.
    Lee H; Kim HT; Yun Y
    J Biol Chem; 1998 Jul; 273(31):19786-91. PubMed ID: 9677410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear respiratory factor 1 plays an essential role in transcriptional initiation from the hepatitis B virus x gene promoter.
    Tokusumi Y; Zhou S; Takada S
    J Virol; 2004 Oct; 78(20):10856-64. PubMed ID: 15452206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemistry and functions of hepatitis B virus X protein.
    Koike K; Takada S
    Intervirology; 1995; 38(1-2):89-99. PubMed ID: 8666528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation.
    Truant R; Antunovic J; Greenblatt J; Prives C; Cromlish JA
    J Virol; 1995 Mar; 69(3):1851-9. PubMed ID: 7853526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cloning and characterization of the mouse JDP2 gene promoter reveal negative regulation by p53.
    Xu Y; Jin C; Liu Z; Pan J; Li H; Zhang Z; Bi S; Yokoyama KK
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1531-6. PubMed ID: 25026555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53.
    St Clair S; Manfredi JJ
    Cell Cycle; 2006 Apr; 5(7):709-13. PubMed ID: 16582636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A transcription initiation site for the hepatitis B virus X gene is directed by the promoter-binding protein.
    Yaginuma K; Nakamura I; Takada S; Koike K
    J Virol; 1993 May; 67(5):2559-65. PubMed ID: 8474161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter.
    Lee H; Lee YH; Huh YS; Moon H; Yun Y
    J Biol Chem; 1995 Dec; 270(52):31405-12. PubMed ID: 8537415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Transactivation function of HBV X protein and tumor suppressor gene p53].
    Takada S
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):82-8. PubMed ID: 12442365
    [No Abstract]   [Full Text] [Related]  

  • 51. Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene.
    Zhao J; Schmieg FI; Simmons DT; Molloy GR
    Mol Cell Biol; 1994 Dec; 14(12):8483-92. PubMed ID: 7969181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional repression by p53 through direct binding to a novel DNA element.
    Johnson RA; Ince TA; Scotto KW
    J Biol Chem; 2001 Jul; 276(29):27716-20. PubMed ID: 11350951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel pathological role of p53 in kidney development revealed by gene-environment interactions.
    Fan H; Harrell JR; Dipp S; Saifudeen Z; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F98-107. PubMed ID: 15383401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression.
    Ruiz-Lozano P; Hixon ML; Wagner MW; Flores AI; Ikawa S; Baldwin AS; Chien KR; Gualberto A
    Cell Growth Differ; 1999 May; 10(5):295-306. PubMed ID: 10359011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A cellular repressor regulates transcription initiation from the minute virus of mice P38 promoter.
    Krauskopf A; Aloni Y
    Nucleic Acids Res; 1994 Mar; 22(5):828-34. PubMed ID: 8139925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.
    van Bodegom D; Roessingh W; Pridjian A; El Dahr SS
    Biochim Biophys Acta; 2010 Jul; 1799(7):502-9. PubMed ID: 20388565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Viral cis-regulatory elements as sensors of cellular states and environmental cues.
    Rottenberg JT; Taslim TH; Soto-Ugaldi LF; Martinez-Cuesta L; Martinez-Calejman C; Fuxman Bass JI
    Trends Genet; 2024 Sep; 40(9):772-783. PubMed ID: 38821843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran.
    Moradi A; Zhand S; Ghaemi A; Javid N; Bazouri M; Tabarraei A
    Iran J Basic Med Sci; 2014 May; 17(5):370-7. PubMed ID: 24967066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients.
    Cho EY; Kim HC; Choi CS; Shin SR; Park C; So HS; Kim HJ; Park R; Cho JH; Moon HB
    Cancer Sci; 2010 Aug; 101(8):1905-12. PubMed ID: 20550526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of transcription from TATA-less promoters: identification of a new core promoter element XCPE2 and analysis of factor requirements.
    Anish R; Hossain MB; Jacobson RH; Takada S
    PLoS One; 2009; 4(4):e5103. PubMed ID: 19337366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.